首页> 外文期刊>Pharmacology: International Journal of Experimental and Clinical Pharmacology >Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages
【24h】

Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages

机译:硫化氢对不同年龄转基因小鼠的严重阿尔茨海默病进展的机制

获取原文
获取原文并翻译 | 示例
       

摘要

Backgroud: Alzheimer disease is an age-related severe neurodegenerative pathology. The level of the third endogenous gas, hydrogen sulfide (H2S), is decreased in the brain of Alzheimer's disease (AD) patients compared with the brain of the age-matched normal individuals; also, plasma H2S levels are negatively correlated with the severity of AD. Recently, we have demonstrated that systemic H2S injections are neuroprotective in an early phase of preclinical AD. Objectives: This study focuses on the possible neuroprotection of a chronic treatment with an H2S donor and sulfurous water (rich of H2S) in a severe transgenic 3xTg-AD mice model. Method: 3xTg-AD mice at 2 different ages (6 and 12 months) were daily treated intraperitoneally with an H2S donor and sulfurous water (rich of H2S) for 3 months consecutively. We investigated the cognitive ability, brain morphological alterations, amyloid/tau cascade, excitotoxic, inflammatory and apoptotic responses. Results: Three months of treatments with H2S significantly protected against impairment in learning and memory in a severe 3xTg-AD mice model, at both ages studied, and reduced the size of Amyloid beta plaques with preservation of the morphological picture. This neuroprotection appeared mainly in the cortex and hippocampus, associated with reduction in activity of c-jun N-terminal kinases, extracellular signal-regulated kinases and p38, which have an established role not only in the phosphorylation of tau protein but also in the inflammatory and excitotoxic response. Conclusion: Our findings indicate that appropriate treatments with various sources of H2S, might represent an innovative approach to counteract early and severe AD progression in humans. (C) 2018 S. Karger AG, Basel
机译:Backgroud:阿尔茨海默病是一种与年龄相关的严重神经变性病理学。与年龄匹配的正常个人的大脑相比,在阿尔茨海默病(AD)患者的脑中降低了第三内源气体,硫化氢(H2S)的水平;此外,血浆H 2 S水平与广告的严重程度负相关。最近,我们已经证明,在临床前AD的早期阶段,全身H2S注射是神经保护性。目的:该研究侧重于在严重的转基因3XTG-AD小鼠模型中用H 2 S供体和含硫水(富含H2S)的慢性治疗的可能神经保护。方法:每天3个月,连续3个月,每天2种不同年龄(6和12个月)的3XTG-AD小鼠每天用H 2 S供体和硫磺水(富含H 2 S)治疗。我们调查了认知能力,脑形态改变,淀粉样蛋白/ Tau级联,兴奋毒性,炎症和凋亡反应。结果:在研究的两年龄段,在严重的3XTG-AD小鼠模型中,三个月的H2S治疗免受学习和记忆障碍的影响,并减少了淀粉样蛋白β斑块的尺寸,并保存了形态学图。这种神经保护作用主要在皮质和海马中出现,与C-JUM N-末端激酶,细胞外信号调节激酶和P38的活性的减少相关,其不仅在TAU蛋白的磷酸化中具有既定作用,也存在于炎症中和兴奋毒性反应。结论:我们的研究结果表明,具有各种H2S来源的适当治疗,可能代表了一种抵消人类早期和严重广告进展的创新方法。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号